Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
- Published In:
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 31(2), 249-54 (2016)
- Authors:
- Critselis, Elena, Lambers Heerspink, Hiddo
- Database ID:
- RPEP-02904
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02904APA
Critselis, Elena; Lambers Heerspink, Hiddo. (2016). Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 31(2), 249-54. https://doi.org/10.1093/ndt/gfv062
MLA
Critselis, Elena, et al. "Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.." Nephrology, 2016. https://doi.org/10.1093/ndt/gfv062
RethinkPeptides
RethinkPeptides Research Database. "Utility of the CKD273 peptide classifier in predicting chron..." RPEP-02904. Retrieved from https://rethinkpeptides.com/research/critselis-2016-utility-of-the-ckd273
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.